Bioorganic

264 papers17 directions
Bioorganic is a research venue that has been active since 1991, with a collection of 263 papers documented through 2026. The venue focuses on the intersection of chemical biology and drug discovery, providing a platform for research into the design, synthesis, and biological evaluation of small molecules. Its scope encompasses a variety of therapeutic areas, including oncology, immunology, and antifungal treatments. Prolific contributors to the venue include researchers such as Thierry Langer, Andreas Verras, and Dong‐Ming Shen. The research published at Bioorganic frequently centers on the identification of potent inhibitors and the development of novel molecular scaffolds. Sample studies include the discovery of mTOR inhibitors for acute myeloid leukemia, URAT1 inhibitors with hypouricemic effects, and the design of PD-L1-targeted molecules for cancer therapy. The venue also features work on molecular glue degraders and natural product-inspired derivatives, reflecting a focus on diverse chemical strategies for modulating biological targets. In the context of machine learning and computational research, Bioorganic serves as a site for the application of molecular design technologies and structural analysis. The venue documents the use of emerging insights in immunomodulatory technologies and the identification of selective inhibitors, such as those targeting ROCK2 or tubulin polymerization. By publishing detailed findings on structure-activity relationships and oral bioavailability, the venue contributes to the data and methodologies used in the computational screening and optimization of therapeutic candidates.

Papers by Year

2026 1
2025 38
2024 17
2023 14
2022 22
2021 8
2020 14
2019 12
2018 7
2017 9
2016 7
2015 13
2014 10
2013 11
2012 11
2011 5
2010 13
2009 10
2008 8
2007 4
2006 4
2005 6
2004 4
2003 4
2002 4
2001 1
1998 3
1996 2
1994 1
1991 1

Top Research Directions

Research directions most represented by papers from this venue.

Stereochemical Determinants of Pharmacological Efficacy 1
Principles of Covalent Target Inhibition 1
Validating Target Specificity Through Competitive Displacement 1
Mapping Chemical Structure to Biological Activity 1
Off-Target Binding Mechanisms in Positron Emission Tomography 1
Radiolabeled Tracers for Mapping Therapeutic Macromolecule Delivery 1
Atomic Level Refinement of Predicted Molecular Geometries 1
Validating Novel Molecular Targets for Clinical Success 1
Spectroscopic Structure Elucidation of Complex Natural Products 1
Mapping Traditional Remedies to Modern Molecular Pathways 1
Deconstructing the Pharmacology of Multi Component Herbal Formulas 1
Translating Genetic Target Validation into Small Molecule Inhibitors 1
Stepwise Selection for Parsimonious Regression Modeling 1
Genome-Wide Gene Expression Profiling Using Microarrays 1
RT-qPCR Validation for Reliable Transcriptomic Analysis 1

Top Authors

AuthorPapers
Thierry Langer11
Alicia Higueruelo3
George Hripcsak3
Bowei Zhang2
Hyunwoo Kim2
Lars Olsen2
Pan Li2
Alessandro Sperduti1
Andrew Anighoro1
Chenxi Xiao1
Christian Wolfgang Feldmann1
Duo Xu1
Fei Gu1
Hui Ji1
Jing Zhang1
Shinichi Furuya1
Sichao Tian1
Wei Wei1
Xiao Ding1
Yang Liu1

Impactful Papers

Papers from this venue that shaped research clusters.

Foundational

Influential

Related Venues

Venues with the most similar research cluster distributions.

Papers

TitleYear
Design and an efficient synthesis of natural product-based cyclopenta[b]pyran derivatives with potential bioactivity2010
Design and an efficient synthesis of new thiorotenone derivatives2010
Design and efficient synthesis of A-278637 derivatives as potential potassium channel opener2010
Discovery of novel 1-phenyl-cycloalkane carbamides as potent and selective influenza fusion inhibitors2010
First identification of xanthone sulfonamides as potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors2010
Highly brominated metabolites from marine red alga Laurencia similis inhibit protein tyrosine phosphatase 1B2010
Identification of novel bacterial histidine biosynthesis inhibitors using docking, ensemble rescoring, and whole-cell assays2010
Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screening2010
Morphinans and isoquinolines: Acetylcholinesterase inhibition, pharmacophore modeling, and interaction with opioid receptors2010
On the inhibition of histone deacetylase 82010
Synthesis and antibacterial activities of a novel alkylide: 3-O-(3-aryl-2-propargyl) and 3-O-(3-aryl-2-propenyl)clarithromycin derivatives2010
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors2010
20(R)-Ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity2009
5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors2009
Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A2A and A3 receptor pyrazolo-t2009
Designed DNA probes from the neocarzinostatin family: Impact of glycosyl linkage stereochemistry on bulge base binding2009
Detection of multiple network-based allosteric interactions between peptides and arrays of DNA binding sites2009
Low molecular weight non-peptide mimics of ω-conotoxin GVIA2009
Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compounds2009
Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors2009
Synthesis and biological evaluation of pyrrolopyridazine derivatives as novel HER-2 tyrosine kinase inhibitors2009
ω-Conotoxin GVIA mimetics based on an anthranilamide core: Effect of variation in ammonium side chain lengths and incorporation of fluorine2009
Discovery of GSK345931A: An EP1 receptor antagonist with efficacy in preclinical models of inflammatory pain2008
Efficient parallel synthesis of macrocyclic peptidomimetics2008
Heme activates artemisinin more efficiently than hemin, inorganic iron, or hemoglobin2008
Inhibition of Candida albicans isocitrate lyase activity by sesterterpene sulfates from the tropical sponge Dysidea sp.2008
IRAK-4 inhibitors. Part 1: A series of amides2008
IRAK-4 inhibitors. Part II: A structure-based assessment of imidazo[1,2-a]pyridine binding2008
IRAK-4 inhibitors. Part III: A series of imidazo[1,2-a]pyridines2008
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives2008
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases2007
A polyacetylene compound from herbal medicine regulates genes associated with thrombosis in endothelial cells2007
Evaluation of in vitro aldose redutase inhibitory activity of 5-arylidene-2,4-thiazolidinediones2007
Synthesis of novel neutrophil-specific imaging agents for Positron Emission Tomography (PET) imaging2007
Design and synthesis of furoxan-based nitric oxide-releasing glucocorticoid derivatives with potent anti-inflammatory activity and improved safety2006
Design, synthesis, and SAR analysis of novel selective σ1 ligands2006
Factor VIIa inhibitors: Gaining selectivity within the trypsin family2006
Molecular probes of DNA bulges: Functional assay and spectroscopic analysis2006
Active site binding modes of curcumin in HIV-1 protease and integrase2005
Constructing plasma protein binding model based on a combination of cluster analysis and 4D-fingerprint molecular similarity analyses2005
Development of α-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease2005
New leads of metallo-β-lactamase inhibitors from structure-based pharmacophore design2005
Structure–activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors2005
Synthesis and evaluation of diverse analogs of amygdalin as potential peptidomimetics of peptide T2005
Design, synthesis, and evaluation of oxyanion-hole selective inhibitor substituents for the S1 subsite of factor Xa2004
Inhibition studies with rationally designed inhibitors of the human low molecular weight protein tyrosine phosphatase2004
QSAR Studies of PC-3 cell line inhibition activity of TSA and SAHA-like hydroxamic acids2004
Structure-based de novo design of ligands using a three-dimensional model of the insulin receptor2004
A biaryl peptide crosslink in a MetJ peptide model confers cooperative, nonspecific binding to DNA that ablates both repressor binding and In vitro transcription2003
Affinity and intrinsic efficacy (IE) of 5′-carbamoyl adenosine analogues for the A1 adenosine receptor—efforts towards the discovery of a chronic ventricular rate control agent for the treatment of at2003

« prev Page 5/6 next »